Specialty Pharmacy

Top news of the week in oncology and cancer drug development.

New at-risk group for skin cancer identified.

Biological products will be designated with 4-letter suffixes devoid of meaning.

FDA finalizes guidance for nonproprietary naming of biological products.

Americans living in rural areas more likely to die from top 5 causes of death, including cancer.

CBI Channel Trends Trade and Specialty Data conference delves into the core topics in the supply chain for both traditional and specialty products.

Beneficial effects seen in blocking the immune response against HIV.

A $1 million competition announced with a goal of reducing lung cancer deaths by 20%.

Top news of the week on Specialty Pharmacy Times.

NCPA emphasizes that a replacement for the Affordable Care Act must preserve prescription drug coverage to help reduce overall health care costs.

President-elect Donald Trump took aim at the pharmaceutical industry, causing significant losses in the market for several manufacturers.

Specialty pharmacies concerned that pharmacy benefit managers are directing patients to their own in-house pharmacies.

Higher intake of grilled, barbecued, and smoked meats increases mortality risk among cancer survivors.

Many specialty pharmacies have filed lawsuits against PBMs alleging the companies are steering customers towards their own pharmacies.

This biosimilar payment model is designed to create a significant financial incentive for physicians to prescribe these drugs.

Drug combination more effective on cancer cell proliferation.

A drug marketed as a potential cure for cancer has not been approved for any indications and may contain harmful bacteria.

Medrad Intego PET Infusion System recalled due to particulate matter in medicine vials.

Top news of the day from across the health care landscape.

HIV treatment guidelines typically do not address specific characteristics for gay, bisexual, and men who have sex with men.

Investigators identify factors that contribute to the chronic nature of autoimmune diseases.

Investigational treatment for scleroderma autoimmune disease shows high efficacy in melanoma patients.

Company seeks to leverage technologies to address unmet needs.

Mark Tesell, PharmD, BCPS, discusses trends that could impact specialty pharmacy well into the future.

Small molecule inhibitor presents promising treatment option for glioblastoma tumors.

Top news of the day from across the health care landscape.

National and global HIV guidelines recommend initiating antiretroviral therapy in all patients, regardless of CD4 count.

Specialty pharmacies dispensing erythropoiesis-stimulating agents can improve outcomes by effectively monitoring patients.